Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Surgerii Technology
company
About
Surgerii Technology is a developer of minimally invasive surgical robots.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Industries
- Medical,Robotics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design and integration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Surgerii Technology has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2022 | Series C | — | 2 | — | — | Detail |
| Nov 2, 2021 | Series B | — | 1 |
Medtronic
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Surgerii Technology is funded by 2 investors.
Medtronic
and Tianfeng Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Medtronic
|
— | Series C |
Tianfeng Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
